When CML was induced by bone marrow transplantation with BCR-ABL-expressing hematopoeitic cells, the combined treatment with plerixafor and TKIs failed to reduce leukemia burden over TKIs alone [82]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.